The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity
By J. Barretina, G. Caponigro, Nicolas Stransky, K. Venkatesan, Adam A. Margolin, Sungjoon Kim, Christopher J. Wilson, Joseph Lehar, G. Kryukov, D. Sonkin and 51 more. Nature, 2012
7,455 citations recorded by the source corpus.
The systematic translation of cancer genomic data into knowledge of tumour biology and therapeutic possibilities remains challenging. Such efforts should be greatly aided by robust preclinical model systems that reflect the genomic diversity of human cancers and for which detailed genetic and pharmacological annotation is available. Here we describe the Cancer Cell Line Encyclopedia (CCLE): a compilation of gene expression, chromosomal copy number and massively parallel sequencing data from 947 human cancer cell lines. When coupled with pharmacological profiles for 24 anticancer drugs across 479 of the cell lines, this collection allowed identification of genetic, lineage, and gene-expression-based predictors of drug sensitivity. In addition to known predictors, we found that plasma cell lineage correlated with sensitivity to IGF1 receptor inhibitors; AHR expression was associated with MEK inhibitor efficacy in NRAS-mutant lines; and SLFN11 expression predicted sensitivity to topoisomerase inhibitors. Together, our results indicate that large, annotated cell-line collections may help to enable preclinical stratification schemata for anticancer agents. The generation of genetic predictions of drug response in the preclinical setting and their incorporation into cancer clinical trial design could speed the emergence of ‘personalized’ therapeutic regimens.
Subfields: Cancer Research, Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/47a0bc0ca7029e356059ad60a7b1df1e687f74eb
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- Yuhao Chen
- Gad Getz
- Tero Aittokallio
- Mehreen Ali
- Manel Esteller
- Phillip A. Sharp
- David M. Sabatini
- Núria López-Bigas
In Molecular Biology
- David M. Sabatini
- Eric S. Lander
- K. Guan
- Feng Zhang
- Manel Esteller
- Albert-László Barabási
- Peter A. Jones
- Hans Clevers
In Oncology
Citations in the corpus
- PGC1α Expression Defines a Subset of Human Melanoma Tumors with Increased Mitochondrial Capacity and Resistance to Oxidative Stress (2013, neutral): “org/ccle) (Barretina et al., 2012).”
- In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform (2016, methodology): “The molecular profiles of a large number of human cancer cell lines are available in the Cancer Cell Line Encyclopedia (Barretina et al., 2012), and these profiles can be compared to the profiles of a large number of human tumors, compiled as part of the Cancer Genome Atlas Research Network (Hollida”
- MOLI: multi-omics late integration with deep neural networks for drug response prediction (2019, background): “We note that the classifier was validated only on CCLE cell lines without studying its translatability to patients or PDX models.”
- Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines (2018, neutral): “There are a number of cancer genomics projects working to do analysis on increasingly large datasets (Table 1) (Barretina et al., 2012; Brunner and Graubert, 2018; Campbell et al., 2017; Hartmaier et al., 2017; Turnbull, 2018; Project GENIE, 2017).”
- The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins (2016, background): “Integration with the recently published cancer cell-line sensitivity data is an alternative (27,30, 31,134).”